1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

12 Mar 2024
Admin
News Article

WHO Published Diagnostic Manual for ICD-11 Disorders

WHO releases new manual to support diagnosis of mental, behavioural and neurodevelopmental disorders added in ICD-11

Overview

World Health Organization (WHO) has published a new, comprehensive diagnostic manual for mental, behavioural, and neurodevelopmental disorders: “The clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders (ICD-11 CDDR)”.

Process Behind Manual

The manual has been developed using the latest available scientific evidence and best clinical practices and is designed to support qualified mental health and other health professionals to identify and diagnose mental, behavioural and neurodevelopmental disorders in clinical settings.

WHO on Manual

An accurate diagnosis is often the first critical step towards receiving appropriate care and treatment. By supporting clinicians to identify and diagnose mental, behavioural and neurodevelopmental disorders, this new ICD-11 diagnostic manual will ensure more people are able to access the quality care and treatment they need” said Dévora Kestel, director, mental health and substance use department, World Health Organization.

Features of New Guidelines:-

Guidance on diagnosis for several new categories added in ICD-11, including complex post-traumatic stress disorder, gaming disorder and prolonged grief disorder.
This enables improved support to health professionals to better recognize distinct clinical features of these disorders, which may previously have been undiagnosed and untreated.
The adoption of a lifespan approach to mental, behavioural and neurological disorders, including attention to how disorders appear in childhood, adolescence, and older adults.
The provision of culture-related guidance for each disorder, including how disorder presentations may differ systematically by cultural background.
The incorporation of dimensional approaches, for example in personality disorders, recognizing that many symptoms and disorders exist on a continuum with typical functioning.

Target Professionals

The ICD-11 CDDR are aimed at mental health professionals and qualified non-specialist health professionals such as primary care physicians responsible for assigning these diagnoses in clinical settings as well as other health professionals in clinical and non-clinical roles, such as nurses, occupational therapists and social workers, who need to understand the nature and symptoms of mental, behavioural and neurodevelopmental disorders even if they do not personally assign diagnoses.

Development Approach

The ICD-11 CDDR were developed and field-tested through a rigorous, multi-disciplinary and participatory approach involving hundreds of experts and thousands of clinicians from around the world.

CDDR

The CDDR are a clinical version of ICD-11 and thus complementary to the statistical reporting of health information, referred to as the linearization for mortality and morbidity statistics (MMS).

WHO Revision

The World Health Organization (WHO) Eleventh Revision of the International Classification of Diseases (ICD-11) is a global standard for recording and reporting diseases and health related conditions. It provides standardized nomenclature and common health language for health practitioners across the world.

ICD-11 was adopted at the World Health Assembly in May 2019 and came into effect formally in January 2022.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!